Sunshine Biopharma (SBFM) Interest Expenses (2012 - 2026)
Sunshine Biopharma's (SBFM) quarterly Interest Expenses came in at $180634.0 in Q1 2026, down 2.23% YoY from $184762.0 in Q1 2025, and down 5.33% on a QoQ basis from $190801.0 in Q3 2025.
Sunshine Biopharma (SBFM) Interest Expenses (2012 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 14 years of Interest Expenses data on file, last reported at $180634.0 in Q1 2026.
- Quarterly Interest Expenses fell 2.23% year-over-year to $180634.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $180634.0 (down 2.23% YoY) and the FY2025 annual result came in at $8.4 million, up 21.22% from the prior year.
- Interest Expenses slipped to $180634.0 in Q1 2026, from $190801.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $194689.0 in Q2 2025 to a low of -$12864.0 in Q4 2022.
- A 5-year average of $95159.5 and a median of $103636.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses tumbled 100.0% — and 2023, when it surged 5506600.0%.
- Tracing SBFM's Interest Expenses over 5 years: stood at -$12864.0 in 2022, then surged by 334.06% to $30110.0 in 2023, then plunged by 73.83% to $7881.0 in 2024, then jumped by 2321.03% to $190801.0 in 2025, then dropped by 5.33% to $180634.0 in 2026.
- The last three Interest Expenses figures came in at $180634.0 (Q1 2026), $190801.0 (Q3 2025), and $194689.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Sunshine Biopharma | 1.53 Mn | -12.22 Mn | 2.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 177,190.00 |
| Jun 30, 2026 | 177,190.00 |
| Mar 31, 2026 | 180,634.00 |
| Mar 31, 2026 | 180,634.00 |
| Sep 30, 2025 | 190,801.00 |
| Sep 30, 2025 | 190,801.00 |
| Jun 30, 2025 | 194,689.00 |
| Jun 30, 2025 | 194,689.00 |
| Mar 31, 2025 | 184,762.00 |
| Mar 31, 2025 | 184,762.00 |
| Dec 31, 2024 | 7,881.00 |
| Dec 31, 2024 | 7,881.00 |
| Sep 30, 2024 | 103,897.00 |
| Sep 30, 2024 | 103,897.00 |
| Jun 30, 2024 | 102,470.00 |
| Jun 30, 2024 | 102,470.00 |
| Mar 31, 2024 | 103,506.00 |
| Mar 31, 2024 | 103,506.00 |
| Dec 31, 2023 | 30,110.00 |
| Dec 31, 2023 | 30,110.00 |